Shattuck Labs

Shattuck Labs

  • Founded: 2016
  • Location: Durham, NC
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Ovarian cancer
  • Drug types: ONC, IMM
  • Lead product: SL-172154
  • Product link:
  • Funding: $232M IPO Oct 2020; $118M Jun 2020; $46M May 2018
  • Investors: Redmile Group

job board

Short description:

Immunotherapy platform

Drug notes:

Also second combo Clin1 ovarian cancer, Clin1 AML, MDS; undisclosed programs Clin0 oncology, autoimmune conditions

Long description:

Contact us to add description:


Shattuck Labs
Associate Director, Downstream Process Dev.
Shattuck Labs, Durham, NC, US|32 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy